FMR LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$825,793,457
-20.7%
30,427,172
-10.2%
0.07%
-18.4%
Q2 2023$1,041,601,849
-63.8%
33,884,250
-57.6%
0.09%
-34.1%
Q1 2023$2,881,255,400
+65.3%
79,968,232
+81.3%
0.13%
-23.7%
Q4 2022$1,743,241,625
+1.0%
44,110,365
+2.7%
0.17%
-3.9%
Q3 2022$1,726,046,000
+14.2%
42,957,880
+19.5%
0.18%
+19.2%
Q2 2022$1,511,480,000
+37.5%
35,953,354
+27.5%
0.15%
+71.6%
Q1 2022$1,098,872,000
+24.9%
28,205,161
+27.7%
0.09%
+35.4%
Q4 2021$879,880,000
+27.4%
22,079,795
+15.5%
0.06%
+18.2%
Q3 2021$690,627,000
-30.1%
19,109,757
-20.7%
0.06%
-28.6%
Q2 2021$987,693,000
-19.0%
24,095,929
-13.8%
0.08%
-26.0%
Q1 2021$1,219,302,000
-2.3%
27,952,820
+12.1%
0.10%
-6.3%
Q4 2020$1,248,374,000
+65.6%
24,942,548
+37.1%
0.11%
+46.1%
Q3 2020$753,864,000
+1.4%
18,188,304
+11.2%
0.08%
-7.3%
Q2 2020$743,419,00016,356,4910.08%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$294,957,00088.74%
Vantage Consulting Group Inc 8,705,551$379,735,00076.23%
Memorial Sloan Kettering Cancer Center 2,680,644$116,930,00072.07%
HARVARD MANAGEMENT CO INC 10,714,284$467,357,00026.11%
ROBERT WOOD JOHNSON FOUNDATION 970,151$4,231,798,00021.59%
Brown University 381,759$16,652,00011.44%
Overbrook Management Corp 771,155$33,638,0007.48%
SpiderRock Advisors, LLC 778,800$34,236,0004.79%
Renaissance Capital LLC 452,948$19,758,0002.93%
Lagoda Investment Management, L.P. 104,835$4,573,0002.28%
View complete list of ROYALTY PHARMA PLC shareholders